# Passage BIO, Inc. — Form D

Passage BIO, Inc. of PHILADELPHIA, PA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-09-06. The offering totals $110.0M, of which $110.0M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2019-09-06
- Form: D
- Accession: 0001787297-19-000001
- Industry: Other Health Care
- Exemptions: 06b, 3C, 3C.1
- Total offering: $110.0M
- Amount sold: $110.0M
- Remaining: $26
- Investors: 15
- Date of first sale: 2019-08-21
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-348117

## Issuer

- Name: Passage BIO, Inc.
- CIK: 0001787297
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: TWO COMMERCE SQUARE, PHILADELPHIA, PA, 19103
- Phone: 2678660312

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| CARL GORDON | Director | SAN DIEGO, CA |
| Patrick Heron | Director | Philadelphia, PA |
| Saqib Islam | Director | Stamford, CT |
| Stephen Squinto | Director | Stamford, CT |
| Thomas Street Address 1 Woiwode | Director | Philadelphia, PA |
| Tadataka Yamada | Director | Philadelphia, PA |
| Stephen Squinto | Executive Officer | Stamford, CT |
| Tadataka Yamada | Executive Officer | Philadelphia, PA |
| Tadataka Yamada | Promoter | Philadelphia, PA |

## More

- [CIK 1787297 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1787297&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001787297-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.